Added to YB: 2025-12-10
Pitch date: 2025-12-05
HIMS [neutral]
Hims & Hers Health, Inc.
-48.32%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$39.34
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Big news: Hims & Hers acquires YourBio Health, approves a share buyback program and enters into the Canadian market.
HIMS (update): Acquired YourBio's painless microneedle blood collection tech (TAP/HALO devices) for home diagnostics integration, closing early 2026. Enables at-home blood tests up to 900µL volume, removing needle phobia barriers. $250M buyback approved. Launched in Canada via Livewell acquisition. Blood testing market $104B growing to $212-250B by 2032-35.
Read full article (5 min)